Postgraduate Medical Journal,
Год журнала:
2023,
Номер
100(1183), С. 289 - 296
Опубликована: Дек. 30, 2023
Abstract
In
the
evolution
of
modern
medicine,
artificial
intelligence
(AI)
has
been
proven
to
provide
an
integral
aspect
revolutionizing
clinical
diagnosis,
drug
discovery,
and
patient
care.
With
potential
scrutinize
colossal
amounts
medical
data,
radiological
histological
images,
genomic
data
in
healthcare
institutions,
AI-powered
systems
can
recognize,
determine,
associate
patterns
impactful
insights
that
would
be
strenuous
challenging
for
clinicians
detect
during
their
daily
practice.
The
outcome
AI-mediated
search
offers
more
accurate,
personalized
diagnoses,
guides
research
new
therapies,
provides
a
effective
multidisciplinary
treatment
plan
implemented
patients
with
chronic
diseases.
Among
many
promising
applications
AI
imaging
stands
out
distinctly
as
area
tremendous
potential.
algorithms
now
accurately
sensitively
identify
cancer
cells
other
lesions
images
greater
accuracy
sensitivity.
This
allows
earlier
diagnosis
treatment,
which
significantly
impact
outcomes.
review
comprehensive
insight
into
diagnostic,
therapeutic,
ethical
issues
advent
medicine.
CA A Cancer Journal for Clinicians,
Год журнала:
2025,
Номер
unknown
Опубликована: Янв. 22, 2025
Abstract
Next‐generation
sequencing
has
revealed
the
disruptive
reality
that
advanced/metastatic
cancers
have
complex
and
individually
distinct
genomic
landscapes,
necessitating
a
rethinking
of
treatment
strategies
clinical
trial
designs.
Indeed,
molecular
reclassification
cancer
suggests
it
is
underpinnings
disease,
rather
than
tissue
origin,
mostly
drives
outcomes.
Consequently,
oncology
trials
evolved
from
standard
phase
1,
2,
3
tissue‐specific
studies;
to
tissue‐specific,
biomarker‐driven
trials;
tissue‐agnostic
untethered
histology
(all
drug‐centered
designs
);
and,
ultimately,
patient‐centered
,
N‐of‐1
precision
medicine
studies
in
which
each
patient
receives
personalized,
biomarker‐matched
therapy/combination
drugs.
Innovative
technologies
beyond
genomics,
including
those
address
transcriptomics,
immunomics,
proteomics,
functional
impact,
epigenetic
changes,
metabolomics,
are
enabling
further
refinement
customization
therapy.
Decentralized
potential
improve
access
approaches
for
underserved
minorities.
Evaluation
real‐world
data,
assessment
patient‐reported
outcomes,
use
registry
protocols,
interrogation
exceptional
responders,
exploitation
synthetic
arms
all
contributed
personalized
therapeutic
approaches.
With
greater
1
×
10
12
patterns
alterations
4.5
million
possible
three‐drug
combinations,
deployment
artificial
intelligence/machine
learning
may
be
necessary
optimization
individual
therapy
near
future,
also
permit
discovery
new
treatments
real
time.
Bioactive Materials,
Год журнала:
2024,
Номер
39, С. 492 - 520
Опубликована: Май 30, 2024
Endogenous
regeneration
is
becoming
an
increasingly
important
strategy
for
wound
healing
as
it
facilitates
skin's
own
regenerative
potential
self-healing,
thereby
avoiding
the
risks
of
immune
rejection
and
exogenous
infection.
However,
currently
applied
biomaterials
inducing
endogenous
skin
are
simplistic
in
their
structure
function,
lacking
ability
to
accurately
mimic
intricate
tissue
regulate
disordered
microenvironment.
Novel
biomimetic
with
precise
structure,
chemical
composition,
biophysical
properties
offer
a
promising
avenue
achieving
perfect
regeneration.
Here,
we
outline
recent
advances
materials
induced
from
aspects
structural
functional
mimicry,
physiological
process
regulation,
property
design.
Furthermore,
novel
techniques
including
situ
reprograming,
flexible
electronic
skin,
artificial
intelligence,
single-cell
sequencing,
spatial
transcriptomics,
which
have
contribute
development
highlighted.
Finally,
prospects
challenges
further
research
application
discussed.
This
review
provides
reference
address
clinical
problems
rapid
high-quality
Natural Products and Bioprospecting,
Год журнала:
2024,
Номер
14(1)
Опубликована: Янв. 25, 2024
Abstract
Reacting
to
the
challenges
presented
by
evolving
nexus
of
environmental
change,
defossilization,
and
diversified
natural
product
bioprospecting
is
vitally
important
for
advancing
global
healthcare
placing
patient
benefit
as
most
consideration.
This
overview
emphasizes
importance
synthetic
medicines
security
proposes
areas
research
action
enhance
quality,
safety,
effectiveness
sustainable
medicines.
Following
a
discussion
some
contemporary
factors
influencing
products,
rethinking
paradigms
in
products
interwoven
contexts
Fourth
Fifth
Industrial
Revolutions
based
on
optimization
valuable
assets
Earth.
COP28,
necessary
seek
new
classes
bioactive
metabolites
enzymes
chemoenzymatic
synthesis.
Focus
placed
those
performance
practice
modifications
which,
manner,
establish
patient,
maintenance
their
prophylactic
treatment
needs,
priority.
Forty
initiatives
are
offered
practitioner
promoting
address
issues
sustainability,
quality
control,
consistency,
neglected
diseases
assure
that
medicinal
agents
will
be
accessible
future
generations.
Graphical
Advances in medical diagnosis, treatment, and care (AMDTC) book series,
Год журнала:
2024,
Номер
unknown, С. 304 - 323
Опубликована: Янв. 5, 2024
The
healthcare
industry
is
undergoing
a
momentous
transformation
with
the
advent
of
artificial
intelligence
(AI)
and
internet
medical
things
(IoMT),
as
these
technologies
are
significant
in
managing
patient
data,
simple
surgery,
personnel.
This
development
has
shown
potential
to
mitigate
shortages,
health
issues,
global
disasters.
Nevertheless,
dynamic
characteristics
system
its
vulnerability
intrusions
give
rise
apprehensions
regarding
possible
compromise
endangerment
life,
reputational
harm.
study
examines
influence
robots
AI-aided
diagnostics
on
smart
sustainability.
Molecular Pharmaceutics,
Год журнала:
2024,
Номер
21(4), С. 1563 - 1590
Опубликована: Март 11, 2024
Understanding
protein
sequence
and
structure
is
essential
for
understanding
protein–protein
interactions
(PPIs),
which
are
many
biological
processes
diseases.
Targeting
binding
hot
spots,
regulate
signaling
growth,
with
rational
drug
design
promising.
Rational
uses
structural
data
computational
tools
to
study
sites
interfaces
inhibitors
that
can
change
these
interactions,
thereby
potentially
leading
therapeutic
approaches.
Artificial
intelligence
(AI),
such
as
machine
learning
(ML)
deep
(DL),
has
advanced
discovery
by
providing
resources
methods.
Quantum
chemistry
reactivity,
toxicology,
screening,
quantitative
structure–activity
relationship
(QSAR)
properties.
This
review
discusses
the
methodologies
challenges
of
identifying
characterizing
spots
sites.
It
also
explores
strategies
applications
artificial-intelligence-based
technologies
target
proteins
interaction
(PPI)
spots.
provides
valuable
insights
implications.
We
have
demonstrated
pathological
conditions
heat
shock
27
(HSP27)
matrix
metallopoproteinases
(MMP2
MMP9)
designed
using
paradigm
in
a
case
on
molecules
cancer
treatment.
Additionally,
implications
benzothiazole
derivatives
anticancer
deliberated.
Current Oncology,
Год журнала:
2024,
Номер
31(9), С. 5255 - 5290
Опубликована: Сен. 6, 2024
Artificial
intelligence
(AI)
is
revolutionizing
head
and
neck
cancer
(HNC)
care
by
providing
innovative
tools
that
enhance
diagnostic
accuracy
personalize
treatment
strategies.
This
review
highlights
the
advancements
in
AI
technologies,
including
deep
learning
natural
language
processing,
their
applications
HNC.
The
integration
of
with
imaging
techniques,
genomics,
electronic
health
records
explored,
emphasizing
its
role
early
detection,
biomarker
discovery,
planning.
Despite
noticeable
progress,
challenges
such
as
data
quality,
algorithmic
bias,
need
for
interdisciplinary
collaboration
remain.
Emerging
innovations
like
explainable
AI,
AI-powered
robotics,
real-time
monitoring
systems
are
poised
to
further
advance
field.
Addressing
these
fostering
among
experts,
clinicians,
researchers
crucial
developing
equitable
effective
applications.
future
HNC
holds
significant
promise,
offering
potential
breakthroughs
diagnostics,
personalized
therapies,
improved
patient
outcomes.
Diseases,
Год журнала:
2025,
Номер
13(1), С. 24 - 24
Опубликована: Янв. 20, 2025
Background:
Cancer
remains
a
leading
cause
of
morbidity
and
mortality
worldwide.
Traditional
treatments
like
chemotherapy
radiation
often
result
in
significant
side
effects
varied
patient
outcomes.
Immunotherapy
has
emerged
as
promising
alternative,
harnessing
the
immune
system
to
target
cancer
cells.
However,
complexity
responses
tumor
heterogeneity
challenges
its
effectiveness.
Objective:
This
mini-narrative
review
explores
role
artificial
intelligence
[AI]
enhancing
efficacy
immunotherapy,
predicting
responses,
discovering
novel
therapeutic
targets.
Methods:
A
comprehensive
literature
was
conducted,
focusing
on
studies
published
between
2010
2024
that
examined
application
AI
immunotherapy.
Databases
such
PubMed,
Google
Scholar,
Web
Science
were
utilized,
articles
selected
based
relevance
topic.
Results:
significantly
contributed
identifying
biomarkers
predict
immunotherapy
by
analyzing
genomic,
transcriptomic,
proteomic
data.
It
also
optimizes
combination
therapies
most
effective
treatment
protocols.
AI-driven
predictive
models
help
assess
response
guiding
clinical
decision-making
minimizing
effects.
Additionally,
facilitates
discovery
targets,
neoantigens,
enabling
development
personalized
immunotherapies.
Conclusions:
holds
immense
potential
transforming
related
data
privacy,
algorithm
transparency,
integration
must
be
addressed.
Overcoming
these
hurdles
will
likely
make
central
component
future
offering
more
treatments.